Reinforced Hybrid Collagen Sponges for Tissue Engineering


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We created an anisotropic material based on collagen sponge and reactive polylactide structured by laser photopolymerization. The combination of collagen with reactive polylactide improves the resistance of the formed matrices to biodegradation in comparison with collagen sponge, while the existence of sites with different mechanical characteristics and cell affinity on the matrix provides directed cell growth during their culturing. It was shown that reinforcement of the collagen sponges 7-fold increased the mean Young’s modulus for the hybrid matrix without affecting its cytotoxicity. The developed matrix provides cell adhesion and proliferation along reinforcement lines and can be used for fabrication of tissue engineering constructs.

Sobre autores

K. Bardakova

Institute of Photonics Technologies, Federal Research Centre “Crystallography and Photonics”, Russian Academy of Sciences; Institute of Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow; Moscow

E. Grebenik

Institute of Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow

E. Istranova

Institute of Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow

L. Istranov

Institute of Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow

Yu. Gerasimov

N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow

A. Grosheva

N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow

T. Zharikova

Institute of Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow

N. Minaev

Institute of Photonics Technologies, Federal Research Centre “Crystallography and Photonics”, Russian Academy of Sciences

Email: rubenchail@yandex.ru
Rússia, Moscow

B. Shavkuta

Institute of Photonics Technologies, Federal Research Centre “Crystallography and Photonics”, Russian Academy of Sciences; Institute of Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow; Moscow

D. Dudova

Institute of Photonics Technologies, Federal Research Centre “Crystallography and Photonics”, Russian Academy of Sciences

Email: rubenchail@yandex.ru
Rússia, Moscow

S. Kostyuk

Research Institute for Physical Chemical Problems, Belarusian State University

Email: rubenchail@yandex.ru
Belarus, Minsk

N. Vorob’eva

Institute of Photonics Technologies, Federal Research Centre “Crystallography and Photonics”, Russian Academy of Sciences

Email: rubenchail@yandex.ru
Rússia, Moscow

V. Bagratashvili

Institute of Photonics Technologies, Federal Research Centre “Crystallography and Photonics”, Russian Academy of Sciences

Email: rubenchail@yandex.ru
Rússia, Moscow

P. Timashev

Institute of Photonics Technologies, Federal Research Centre “Crystallography and Photonics”, Russian Academy of Sciences; Institute of Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Email: rubenchail@yandex.ru
Rússia, Moscow; Moscow

R. Chailakhyan

Institute of Photonics Technologies, Federal Research Centre “Crystallography and Photonics”, Russian Academy of Sciences; N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: rubenchail@yandex.ru
Rússia, Moscow; Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies